Staphylococcus aureus vaccine (Valneva)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameStaphylococcus aureus vaccine (Valneva)
Drug Alias Name0657nI Staphylococcus aureus vaccine้‡‘้ป„่‰ฒ่‘ก่„็ƒ่Œ็–ซ่‹— - ้ป˜ๅ…‹S.aureus vaccineV-710
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMediastinitisStaphylococcal InfectionsBacteremia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValneva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsMediastinitisStaphylococcal InfectionsBacteremia

Other Information

ATC CodeN/A
Related LinksN/A